Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Corneal epithelial cell surface
- Molecular classification
- Other, May be most related to cell surface glycoproteins (e.g., mucins)
01
Overview
The corneal epithelial cell surface provides a critical interface between the ocular environment and internal eye tissues. It is composed of tightly connected non-keratinized squamous cells, with microprojections (microvilli, microplicae) and a mucin-rich glycocalyx that facilitate tear film adherence, lubrication, and barrier function against pathogens and environmental insult[4][2][6]. The surface structure allows for rapid cell migration and healing following injury, and maintains corneal transparency[2][3]. While the 'surface' itself is not a molecular drug target, molecules expressed there (such as mucins, junctional proteins, and growth factor receptors) are critical in health and disease. Disruption of the corneal epithelial cell surface can result in increased infection risk, dry eye, and impaired wound healing[2][3][6].
- Other names
- Corneal epithelium surfaceOcular surface epithelial layerCorneal cell apical membrane
02
Mechanism of action
Enhance or preserve mucin layer (tear film stability); Modulate inflammation at surface epithelial cells; Promote epithelial migration and healing (growth factor delivery)
03
Biological functions
Barrier function (prevents pathogen penetration and water loss)Tear film stabilization (glycocalyx binds tear components)Cell-cell adhesion (via junctional complexes)Lubrication/reduced friction (mucin-coated microprojections lower friction during eyelid movement)Cell migration and wound healing
04
Disease associations
Infection (serves as barrier against pathogen adherence)Dry eye syndrome (glycocalyx and mucins implicated)Corneal injury/wound healing disordersOcular surface disease
05
Safety considerations
Drug or preservative toxicity causing surface epithelial cell death or disruptionSurface damage increasing risk of infection, delayed healingTear film destabilization leads to discomfort and dry eye symptoms
06
Interacting drugs
Lubricant eye drops (artificial tears augment surface lubrication; not targeted to 'surface' per se)
3 more in the full profile.
07
Biomarkers
MUC16 and other cell-bound mucinsEpithelial barrier integrity (dye penetration tests)Glycocalyx thickness (imaging; research setting)
Beyond the preview
Go deeper on Corneal epithelial cell surface.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Corneal epithelial cell surface.